Table 4.
Comparison of patients’ perceived level of health and attitudes towards their medicines premedication and postmedication review with the pharmacist
| Patient-reported outcome measure | N | Prereview | Postreview | Mean difference (95% CI) |
| EQ-5D-5L | ||||
| Utility score, mean | 62 | 0.728 | 0.673 | −0.056 (−0.111 to −0.002)* |
| Health states change, n (%) | 64 | |||
| No change | 8 (12.5) | |||
| Improve | 19 (29.7) | |||
| Worsen | 23 (35.9) | |||
| Mixed change | 14 (21.9) | |||
| EQ-VAS, mean | 60 | 0.641 | 0.701 | 0.061 (0.018 to 0.103)* |
| MTBQ | ||||
| Score, median (IQR) | 64 | 5.8 (0–11.5) | 5.8 (1.9–16.3) | |
| Burden categories, n (%) | 64 | |||
| No burden | 17 (26.6) | 17 (26.6) | ||
| Low burden | 30 (46.9) | 26 (40.6) | ||
| Medium burden | 11 (17.2) | 11 (17.2) | ||
| High burden | 6 (9.4) | 10 (15.6) | ||
| rPATD, mean | ||||
| Burden | 54 | 13.03 | 13.31 | 0.28 (−0.71 to 1.26) |
| Appropriateness | 52 | 17.13 | 17.23 | 0.10 (−0.73 to 0.92) |
| Concerns | 54 | 12.00 | 12.33 | 0.33 (−0.95 to 1.61) |
| Involvement | 60 | 21.33 | 21.6 | 0.27 (−0.62 to 1.15) |
| Satisfaction | 62 | 4.13 | 4.11 | −0.02 (−0.29 to 0.25) |
| Willingness | 63 | 4.54 | 4.37 | −0.17 (−0.36 to 0.01) |
*Paired t-test <0.05.
†Using an Irish value set derived from a general population representative sample.
EQ-5D-5L, EuroQol health-related quality of life five-level questionnaire; EQ-VAS, EuroQol-visual analogue scale; MTBQ, Multimorbidity Treatment Burden Questionnaire; rPATD, Revised Patients’ Attitudes Towards Deprescribing.